Bellevue Group’s St Jude Medical STJ Stock Holding History

Bellevue Group’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-60,000	Closed	-$4.68M	–	128
2016 Q2	$4.68M	Sell	60,000 -62,000	-51%	-$4.42M	0.88%	42
2016 Q1	$6.71M	Buy	+122,000	New	+$6.65M	1.22%	25

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bellevue Group's STJ Position: Q3 2016 in Review

Bellevue Group sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 60,000 shares — an estimated $4.68M sold.

Bellevue Group first reported a position in STJ in Q1 2016 and held it in 2 quarters. The position peaked at $6.71M in Q1 2016. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

Bellevue Group reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
Bellevue Group sold 60,000 St Jude Medical shares in Q3 2016, an estimated $4.68M.
Bellevue Group first reported a position in St Jude Medical in Q1 2016 and held it in 2 quarters.
Bellevue Group's St Jude Medical position peaked at $6.71M in Q1 2016.
570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Bellevue Group's 13F filing for Q3 2016, filed 10 Nov 2016.